Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01715649 · ClinicalTrials.gov registry record · NA
Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes
A NA study, sponsored by Sutter Health.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01715649: Completed NA study, sponsored by Sutter Health.
NCT01715649 is a NA study that has completed, run by Sutter Health. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01715649, a NA study, has completed, sponsored by Sutter Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Telehealth remote patient monitoring is a means of using communications technology - such as telephones, computers, and the Internet - to connect patients remotely with their healthcare team from their homes. The investigators hope to learn more about improving healthy behaviors and blood glucose among persons with diabetes using telehealth remote patient monitoring technology to connect directly with nurse care coordinators. The purpose of this study is to evaluate a process for improving blood glucose and healthy behaviors among people with type 2 diabetes using telehealth remote patient monitoring technology with nurse care coordinators. Some of the people in this study will work with a nurse care coordinator who will review your blood glucose weekly and call you at home every month for 3 months, while some of the people in this study will simply receive their normal care. At the end of the study, every participant will be asked questions about how they feel about their health care.
Primary Outcome
Lab test
Interventions
- BEHAVIORAL Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01715649 record still lists
NCT01715649 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose is the first listed.
NCT01715649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01715649 about?
NCT01715649 is a clinical study titled "Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes". Telehealth remote patient monitoring is a means of using communications technology - such as telephones, computers, and the Internet - to connect patients remotely with their healthcare team from their homes. The investigators hope to learn more about improving healthy behaviors and blood glucose am...
What is the current status of trial NCT01715649?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2012-11. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01715649?
The interventions under investigation include: Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose (BEHAVIORAL).
Who is sponsoring clinical trial NCT01715649?
This trial is sponsored by Sutter Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01715649's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia